These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25497247)

  • 1. Procedure timing as a predictor of inhospital adverse outcomes from implantable cardioverter-defibrillator implantation: insights from the National Cardiovascular Data Registry.
    Hsu JC; Varosy PD; Parzynski CS; Chaudhry SI; Dewland TA; Curtis JP; Marcus GM
    Am Heart J; 2015 Jan; 169(1):45-52.e3. PubMed ID: 25497247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry.
    Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):582-90. PubMed ID: 24002030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
    Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
    J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low body mass index but not obesity is associated with in-hospital adverse events and mortality among implantable cardioverter-defibrillator recipients: insights from the National Cardiovascular Data Registry.
    Hsu JC; Varosy PD; Bao H; Wang Y; Curtis JP; Marcus GM
    J Am Heart Assoc; 2012 Dec; 1(6):e003863. PubMed ID: 23316325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-hospital complications associated with reoperations of implantable cardioverter defibrillators.
    Steckman DA; Varosy PD; Parzynski CS; Masoudi FA; Curtis JP; Sauer WH; Nguyen DT
    Am J Cardiol; 2014 Aug; 114(3):419-26. PubMed ID: 24927972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physician procedure volume and complications of cardioverter-defibrillator implantation.
    Freeman JV; Wang Y; Curtis JP; Heidenreich PA; Hlatky MA
    Circulation; 2012 Jan; 125(1):57-64. PubMed ID: 22095828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gender differences in procedure-related adverse events in patients receiving implantable cardioverter-defibrillator therapy.
    Peterson PN; Daugherty SL; Wang Y; Vidaillet HJ; Heidenreich PA; Curtis JP; Masoudi FA;
    Circulation; 2009 Mar; 119(8):1078-84. PubMed ID: 19221223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of an inadequate defibrillation safety margin at ICD implantation: insights from the National Cardiovascular Data Registry.
    Hsu JC; Marcus GM; Al-Khatib SM; Wang Y; Curtis JP; Sood N; Parker MW; Kluger J; Lampert R; Russo AM
    J Am Coll Cardiol; 2014 Jul; 64(3):256-64. PubMed ID: 25034061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in implantable cardioverter-defibrillator outcomes: findings from a prospective defibrillator database.
    MacFadden DR; Crystal E; Krahn AD; Mangat I; Healey JS; Dorian P; Birnie D; Simpson CS; Khaykin Y; Pinter A; Nanthakumar K; Calzavara AJ; Austin PC; Tu JV; Lee DS
    Ann Intern Med; 2012 Feb; 156(3):195-203. PubMed ID: 22312139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater mortality risk among patients with delayed follow-up after implantable cardioverter defibrillator procedures.
    Laksman ZW; Krahn AD; Dorian P; Simpson CS; Crystal E; Healey JS; Khaykin Y; Wang X; Lee DS
    Can J Cardiol; 2014 Jun; 30(6):598-605. PubMed ID: 24882529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data Registry.
    Prutkin JM; Reynolds MR; Bao H; Curtis JP; Al-Khatib SM; Aggarwal S; Uslan DZ
    Circulation; 2014 Sep; 130(13):1037-43. PubMed ID: 25081281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends in patient characteristics and outcomes among Medicare beneficiaries undergoing primary prevention implantable cardioverter-defibrillator placement in the United States, 2006-2010. Results from the National Cardiovascular Data Registry's Implantable Cardioverter-Defibrillator Registry.
    Borne RT; Peterson PN; Greenlee R; Heidenreich PA; Wang Y; Curtis JP; Tzou WS; Varosy PD; Kremers MS; Masoudi FA
    Circulation; 2014 Sep; 130(10):845-53. PubMed ID: 25095884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in Use and In-Hospital Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Undergoing Long-Term Dialysis.
    Pun PH; Parzynski CS; Friedman DJ; Sanders G; Curtis JP; Al-Khatib SM
    Clin J Am Soc Nephrol; 2020 Nov; 15(11):1622-1630. PubMed ID: 32967922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of physician certification and outcomes among patients receiving an implantable cardioverter-defibrillator.
    Curtis JP; Luebbert JJ; Wang Y; Rathore SS; Chen J; Heidenreich PA; Hammill SC; Lampert RI; Krumholz HM
    JAMA; 2009 Apr; 301(16):1661-70. PubMed ID: 19383957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary Venous Dissection from Left Ventricular Lead Placement During Cardiac Resynchronization Therapy With Defibrillator Implantation and Associated in-Hospital Adverse Events (from the NCDR ICD Registry).
    Hsu JC; Varosy PD; Bao H; Dewland TA; Curtis JP; Marcus GM
    Am J Cardiol; 2018 Jan; 121(1):55-61. PubMed ID: 29102348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implantable cardioverter-defibrillator registry risk score models for acute procedural complications or death after implantable cardioverter-defibrillator implantation.
    Haines DE; Wang Y; Curtis J
    Circulation; 2011 May; 123(19):2069-76. PubMed ID: 21537001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term morbidity and mortality after implantable cardioverter-defibrillator implantation with procedural complication: A report from the National Cardiovascular Data Registry.
    Kipp R; Hsu JC; Freeman J; Curtis J; Bao H; Hoffmayer KS
    Heart Rhythm; 2018 Jun; 15(6):847-854. PubMed ID: 28987459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular Fibrillation Conversion Testing After Implantation of a Subcutaneous Implantable Cardioverter Defibrillator: Report From the National Cardiovascular Data Registry.
    Friedman DJ; Parzynski CS; Heist EK; Russo AM; Akar JG; Freeman JV; Curtis JP; Al-Khatib SM
    Circulation; 2018 Jun; 137(23):2463-2477. PubMed ID: 29463509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of short-term complications after implantable cardioverter-defibrillator replacement: results from the Ontario ICD Database.
    Krahn AD; Lee DS; Birnie D; Healey JS; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    Circ Arrhythm Electrophysiol; 2011 Apr; 4(2):136-42. PubMed ID: 21325209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of early complications related to De Novo cardioverter defibrillator implantation insights from the Ontario ICD database.
    Lee DS; Krahn AD; Healey JS; Birnie D; Crystal E; Dorian P; Simpson CS; Khaykin Y; Cameron D; Janmohamed A; Yee R; Austin PC; Chen Z; Hardy J; Tu JV;
    J Am Coll Cardiol; 2010 Feb; 55(8):774-82. PubMed ID: 20170816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.